Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
23.58
-0.91 (-3.72%)
At close: Nov 21, 2024, 4:00 PM
24.08
+0.50 (2.12%)
After-hours: Nov 21, 2024, 4:51 PM EST
Beam Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Buy
Price Target
$45.90
Upside
+94.66%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +239.27% | Nov 7, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $27 → $24 | Hold | Maintains | $27 → $24 | +1.78% | Nov 6, 2024 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $27 → $39 | Hold → Buy | Upgrades | $27 → $39 | +65.39% | Nov 6, 2024 |
| Scotiabank | Scotiabank | Hold Initiates $24 | Hold | Initiates | $24 | +1.78% | Oct 16, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $27 | Hold | Reiterates | $27 | +14.50% | Sep 19, 2024 |
| Jones Trading | Jones Trading | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 17, 2024 |
| Stifel | Stifel | Strong Buy Maintains $66 → $69 | Strong Buy | Maintains | $66 → $69 | +192.62% | Sep 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +239.27% | Aug 22, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $45 → $48 | Buy | Maintains | $45 → $48 | +103.56% | Aug 7, 2024 |
| Barclays | Barclays | Hold Maintains $33 → $31 | Hold | Maintains | $33 → $31 | +31.47% | Aug 7, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $27 | Hold | Reiterates | $27 | +14.50% | Aug 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +239.27% | Jul 23, 2024 |
| Barclays | Barclays | Hold Maintains $42 → $33 | Hold | Maintains | $42 → $33 | +39.95% | May 8, 2024 |
| Wedbush | Wedbush | Buy Reiterates $57 | Buy | Reiterates | $57 | +141.73% | Apr 23, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $57 | Buy | Maintains | $57 | +141.73% | Mar 27, 2024 |
| Barclays | Barclays | Hold Maintains $26 → $42 | Hold | Maintains | $26 → $42 | +78.12% | Feb 28, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.